Brett Johnson is Founder and CEO of OneMedMarket, a New York based research and media company whose mission is to identify and provide a platfrom for the most promising investment opportunities in emerging growth companies in health care and life sciences globally. The company is active in promoting capital access to entrepreneurial companies and is best known for producing the OneMedForum, an annual conference showcasing launched in 2007 and fostering the development of a database of growth companies.
In 2010 he launched the China Forum which is now a partnering conference which runs adjacent to the OneMedForum. In 2014 he founded OneMedChina to bring advanced healthcare and medical technologies to China.
Brett's background as an entrepreneur includes founding the Minnesota Collaborative a regional network that assists emerging companies and annually hosts one of the country’s largest venture capital conferences, where presenting companies have raised in excess of $2 billion since 1994.
He was founder and editor-in-chief of Minnesota Ventures magazine. He was also founder and publisher of Law & Politics magazine, now a Thomson Reuters publication called SuperLawyers.
His healthcare experience began in pharmacy, where he worked with the National Community Pharmacists Association NCPA and founded Cornerdrugstore.com. There, as CEO, he built an online network of almost 2,000 local drugstores throughout the U.S.
His non-profit background includes founding the Environmental Initiative in 1990 to address regional environmental issues by bringing together environmental groups, industry and government. The organization has become a model for other regional environmental initiatives. In 2014 he founded Main Street Policy a think tank concentrating on innovative approaches to improve the performance of the US Congress. He received his degree in economics from Harvard University.
Rong Hui Gao worked as a quarantine doctor for seven years, managing infectious diseases and vaccination programs before he joined Nestle as a regional manager in the Shanghai sales team, in the nutritional department.
Relocating to the UK, Rong Hui joined a pharmaceutical consultancy firm InforMed. He worked in areas of marketing planning, new product launch, market research, and KOL management in the. Clients include AstraZeneca, GSK and Novartis.
After relocating back to China, Rong Hui established a marketing consulting firm in the healthcare industry and provided marketing consultancy services for multinational and local pharmaceutical companies by partnering with Pharmaceutical Marketing Academy (PMA), a UK based pharmaceutical consultancy firm. He then joined BioBay, one of the fastest growing bioclusters in China in 2008, as a Business Development Director, to help and support over dozens of startup companies on funding, government affairs, regulatory issues and financing. Companies are from different sectors: drug development, diagnostics and medical devices and CRO
Rong Hui joined China Medical City (CMC), as a Deputy Commissioner in 2010. CMC is one of the major bio-medical focused clusters in China. Rong Hui was responsible for global business development and collaboration. He worked closely with a wide range of life science companies, to support them to establish their operations in China and help them apply for government incentives, regulatory support, and partnership. Under his leadership, China Medical City successfully finalized some major investment projects with AstraZeneca (brand generic production project), Takeda (GSP project), Boehringer Ingelheim (animal vaccine manufacturing project).
Rong Hui serves as an advisor for Shanghai Zhangjiang Science Park and Suzhou Science & Technology Park. He has been invited as the Chinese life science expert by BioMunich, Lyonbiopole, BioPmed, BioCatalonia and Basel Area during 2012-2014. He also served as a KOL for Philips Medical Innovation Center (China) 2013-2014. Rong Hui is a frequent speaker in numerous international life science events.
Rong Hui founded G-Med Consulting in 2013 in Shanghai and focused on Europen and US SMEs to access to the Chinese life science market. Rong Hui holds a clinical medicine degree in Qingdao University Medical College (1986-1991) and an MBA in Manchester Business School, UK ( 2001-2003).
Brett Johnson Managing Partner United States
Dr. Rong Hui Gao M.D.
Managing Partner China
CHINA BIOVENTURES MANAGEMENT